
An experimental Alzheimer's drug shows promise targeting a different brain protein, new study shows
Read full article: An experimental Alzheimer's drug shows promise targeting a different brain protein, new study showsAn experimental drug might help slow early Alzheimer's disease in a markedly different way than current treatments — by lowering the brain's production of a protein called tau.
















:strip_exif(true):strip_icc(true):no_upscale(true):quality(65)/cloudfront-us-east-1.images.arcpublishing.com/gmg/FMEG7FZSUNFQ7CWD74MS63GW5Y.jpg)
:strip_exif(true):strip_icc(true):no_upscale(true):quality(65)/cloudfront-us-east-1.images.arcpublishing.com/gmg/YEOJXBZMR5DDFBW4A2FIBI44AI.jpg)
:strip_exif(true):strip_icc(true):no_upscale(true):quality(65)/cloudfront-us-east-1.images.arcpublishing.com/gmg/MGWY3XU4FNDS7C3ET75LX3COQQ.jpg)
:strip_exif(true):strip_icc(true):no_upscale(true):quality(65)/cloudfront-us-east-1.images.arcpublishing.com/gmg/Y5WPD4WGA5GALB7YY5SMBYE4PY.jpg)
:strip_exif(true):strip_icc(true):no_upscale(true):quality(65)/cloudfront-us-east-1.images.arcpublishing.com/gmg/IUAVUYJVEVDIHNMYPLVHPJQAVQ.jpg)